Skip to content

Cannabis research published in 2023

Page 6 of 9: studies 101 to 120 of 166, newest first. Back to the cannabis overview

Studies

Value Signals Guiding Choices for Cannabis Versus Non-Drug Rewards in Regular Cannabis Users

March 15, 2023 Will Lawn, Xuejun Hao, Anna B. Konova et al. preprint

Background: Despite the critical role of choice processes in substance use disorders, the neurobehavioral mechanisms guiding human decisions about drugs remain poorly understood. We adapted a neuroeconomic framework to characterize the neural encoding of subjective value (SV) for cannabis versus non-drug rewards (snacks) in near-daily cannabis users. We also assessed the impact of cannabis and...

THC and CBD: Villain versus Hero? Insights into Adolescent Exposure.

International Journal of Molecular Sciences March 9, 2023 Nicholas Pintori, Francesca Caria, Maria Antonietta De Luca et al.

Cannabis is the most used drug of abuse worldwide. It is well established that the most abundant phytocannabinoids in this plant are Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). These two compounds have remarkably similar chemical structures yet vastly different effects in the brain. By binding to the same receptors, THC is psychoactive, while CBD has anxiolytic and antipsychotic...

Experience of Cannabis Use from Adolescence to Adulthood in France: An Interpretative Phenomenological Analysis

International Journal of Environmental Research and Public Health March 1, 2023 S. F. Rezag Bara, M. Mary-Krause, S. Wallez et al.

Levels of cannabis use are high during adolescence, but the proportion of cannabis users among adults is also progressing, often for medical reasons. This study describes the reasons and motivations for using medical cannabis among adults over 30 years old in France. This qualitative study was performed using an interpretative phenomenological analysis. People with a history of cannabis use or...

Obsessive-compulsive disorder after long-term cannabis use – case report

European Psychiatry March 1, 2023 Diana-Elena Nistor, Mihai Corban, Lavinia Horoșan 3 citations

Introduction Obsessive-compulsive disorder (OCD) is characterised by intrusive thoughts and repetitive behaviours that considerably impact general functioning. Recent evidence links the endocannabinoid system to OCD neurobiology, and several case reports describe significant improvement after using dronabinol (synthetic tetrahydrocannabinol) in patients with severe OCD. Nevertheless, to what...

The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review.

European Journal of Clinical Pharmacology March 2023 Ehsan Motaghi, Masoumeh Ghasemi-Pirbaluti, Mohsen Rashidi et al.

Previous studies have shown that tetrahydrocannabinol (THC), the main psychoactive component of cannabis, can impair cognitive abilities. There is also some evidence that cannabidiol (CBD), the most abundant non-intoxicating constituent of cannabis, can attenuate these effects. The purpose of this study was to investigate the effects of THC:CBD oromucosal spray (with equal parts THC and CBD) on...

Cannabis and cognitive deficiency: a descriptive study

European Psychiatry March 1, 2023 M. Kacem, W. Bouali, M. Henia et al.

Introduction Cannabis is the most widely used illicit drug; 3.8% of the world’s population consumes cannabis on a regular basis. Cannabis use–associated alterations in the domain of cognition have been extensively studied. Objectives To research memory deficiency in the young consumers of cannabis in Tunisia. Methods This is a transversal descriptive study conducted during two months (January...

Impact of cannabis use and cannabis cessation on inflammation in patients with psychosis

European Psychiatry March 1, 2023 B. Roméo, V. Lestra, Catherine Martelli et al.

Introduction The vulnerability-stress-inflammation model is a well-known psychopathological model in patients with psychosis. It implies an imbalance of the microglia activation (M1/M2 pathways’ homeostasis) leading to an over-expression of pro-inflammatory cytokines. However, despite a higher prevalence of cannabis (THC) consumption in patients with psychosis, few studies have investigated the...

Effect of D2R, NMDAR and CB1R genetic variants associated with cannabis use and childhood trauma in first-episode psychosis in a Brazilian population

European Psychiatry March 1, 2023 C. Loureiro, Fabiana Corsi-Zuelli, Helene A Fachim et al.

Introduction Gene-environment interactions increase psychosis risk (Gayer-Anderson et al. Soc Psychiatry Psychiatr Epidemiol 2020; 55(5):645-657). However, identifying the genetic variants involved and how they interact with environmental risk factors underlying psychosis remains challenging. Objectives To investigate whether there are gene-environment interactions in the relationships of...

Cannabis use during first episode psychosis in Tunisia

European Psychiatry March 1, 2023 E. Bergaoui, R. Lansari, O. Chehaider et al.

IntroductionCannabis use is frequent among patients with psychotic disorders. However, the relationship between cannabis consumption and transition to psychosis has not been fully elucidated.ObjectivesThe aim of this study was to assess the prevalence of cannabis use in first episode psychosis and its correlation with transistion to psychosis and severity of symptoms.MethodsA cross-sectional...

Risk factors for cannabis use disorders and cannabis psychosis in Japan: Second report of a survey on cannabis-related health problems among community cannabis users using social networking services.

Neuropsychopharmacology Reports March 1, 2023 Yuji Masataka, Takeshi Sugiyama, Yoshiyuki Akahoshi et al.

To determine the risk factors for cannabis use disorders and cannabis psychosis in Japan based on a 2021 online survey among Japanese users of social network services. The 3142 respondents who had used cannabis within the preceding year were categorized into two groups based on the development of cannabis use disorder and/or cannabis psychosis. Analyses were performed to determine these...

Functional hyperconnectivity between corticocerebellar networks and altered decision making in young adult cannabis users: Evidence from 7T and multivariate pattern analysis.

Psychiatry Research Neuroimaging March 1, 2023 Alan N. Francis, Joan A Camprodon, Francesca Filbey PhD

Decision-making (DM) impairments are important predictors of cannabis initiation and continued use. In cannabis users, how decision-making abnormalities related to structural and functional connectivity in the brain are not fully understood. We employed a three-method multimodal image analysis and multivariate pattern analysis (MVPA) on high dimensional 7 tesla MRI images examining functional...

A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products.

Drug and Alcohol Dependence February 26, 2023 Ashley N Dowd, C Austin Zamarripa, Dennis J Sholler et al.

Background: Cannabis-infused products available for oral consumption include food and drink items (i.e., edibles) (e.g., baked goods, gummy-, chocolate-, and hard-candies, beverages/drinks) as well as non-food formulations (e.g., oils/tinctures, pills/capsules). This study characterized the motives, opinions, and subjective experiences associated with the use of these seven subtypes of oral...

The association between cannabis use and subjective memory complaints in older adults in the United States

Journal of the International Neuropsychological Society February 20, 2023 Kyler Mulhauser, B. Hampstead, L. Coughlin et al.

Abstract Objective: The U.S. population is aging and increasing numbers of older adults are using cannabis. Cognitive decline is common in older age and subjective memory complaints (SMC) have been associated with increased risk for dementia. While residual cognitive effects of cannabis use at younger ages are well understood, the links between cannabis use and cognition in older adults is less...

Delta-8-THC association with psychosis: A case report with literature review

Frontiers in Psychiatry February 20, 2023 Chelsea R. Miller, Bradley G. Burk, Rachel E. Fargason et al. 16 citations

Background Cannabis (Δ 9 -THC) is the most commonly consumed illicit drug. The Agricultural Improvement Act of 2018 removed hemp, a strain of Cannabis sativa , as a controlled substance. This law allowed the plant to be processed into its components, which contain <0.3% Δ 9 -THC. As a result, delta-8-tetrahydrocannabinol (Δ 8 -THC), a federally unregulated substance, grew in popularity in 2020....

DOI: 10.3389/fpsyt.2023.1103123 (opens in new tab) Cannabis Psychosis Delta-9-tetrahydrocannabinol Antipsychotic +2

Cannabis as a precursor of psychosis and its relationship with schizophrenia

Salud, Ciencia y Tecnología February 19, 2023 Roberto Carlos Mora Vera, Rosa Elizabeth Solorzano Bernita, Jorge Andrés Lozano Aveiga et al. 2 citations

Introduction: schizophrenia is a chronic mental disease affecting around 24 million people worldwide. Within this disease, it is common to find the consumption of psychoactive substances by patients, with cannabis ranking first on the list; this drug bears a particular relation to schizophrenia through the effects of the cannabinoids proper to that plant. Objective: determine the relationship...

DOI: 10.56294/saludcyt2023262 (opens in new tab) Cannabis Psychosis Schizophrenia object-oriented programming

Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity.

Pharmaceutics February 17, 2023 Valentina Castelli, Gianluca Lavanco, Salvatore Feo et al.

Previous evidence suggests that prenatal exposure to THC (pTHC) derails the neurodevelopmental trajectories towards a vulnerable phenotype for impaired emotional regulation and limbic memory. Here we aimed to investigate pTHC effect on hippocampus-related cognitive functions and markers of neuroplasticity in adolescent male offspring. Wistar rats were exposed to THC (2 mg/kg) from gestational...

DOI: 10.3390/pharmaceutics15020692 (opens in new tab) Full text (opens in new tab) Cb1r expression Adolescent rat offspring Hippocampal excitatory plasticity Prenatal THC Exposure

The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology

International Journal of Molecular Sciences February 15, 2023 Martina di Bartolomeo, Tibor Stark, Serena di Martino et al. 23 citations

Adolescent exposure to cannabinoids as a postnatal environmental insult may increase the risk of psychosis in subjects exposed to perinatal insult, as suggested by the two-hit hypothesis of schizophrenia. Here, we hypothesized that peripubertal Δ9-tetrahydrocannabinol (aTHC) may affect the impact of prenatal methylazoxymethanol acetate (MAM) or perinatal THC (pTHC) exposure in adult rats. We...

DOI: 10.3390/ijms24043907 (opens in new tab) Dopaminergic Schizophrenia object-oriented programming Prefrontal cortex Cannabinoid +6

Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report

Frontiers in Psychiatry February 9, 2023 Anya Ragnhildstveit, Miriam Kaiyo, Matthew Brian Snyder et al. 10 citations

Background A dissociative subtype of posttraumatic stress disorder, known as “D-PTSD”, has been included in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. In addition to meeting criteria for PTSD, patients endorse prominent dissociative symptoms, namely depersonalization and derealization, or detachment from one's self and surroundings. At present, this population is...

Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: a proof-of-concept assessment of the Vigil Index of Cannabis Chemovars

Journal of Cannabis Research February 8, 2023 J. Vigil, S. Stith, Franco Brockelman et al.

Background Little is known about the frequency with which different combinations of phytochemicals (chemovars) arise in Cannabis flower or whether common chemovars are associated with distinct pharmacodynamics and patient health outcomes. This study created a clinically relevant, user-friendly, scalable chemovar indexing system summarizing primary cannabinoid and terpene contents and tested...

The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment

Addiction February 8, 2023 Will Lawn, Katie Trinci, Claire Mokrysz et al. 36 citations

Abstract Background and Aims Long‐term harms of cannabis may be exacerbated in adolescence, but little is known about the acute effects of cannabis in adolescents. We aimed to (i) compare the acute effects of cannabis in adolescent and adult cannabis users and (ii) determine if cannabidiol (CBD) acutely modulates the effects of delta‐9‐tetrahydocannabinol (THC). Design Randomised, double‐blind,...